Cullin 4B is recruited to tristetraprolin-containing messenger ribonucleoproteins and regulates TNF-α mRNA polysome loading

Journal of Immunology

Volumn 188, Issue 4, 2012, Pages 1828-1839

  Pfeiffer, Jason R ^a   Brooks, Seth A ^a,b,c  

^a VA MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c DARTMOUTH COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CULLIN; CULLIN 4B; LIPOPOLYSACCHARIDE; LUCIFERASE; MESSENGER RNA; RIBONUCLEOPROTEIN; SHORT HAIRPIN RNA; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ASSAY; EXOSOME; HALF LIFE TIME; MOUSE; NONHUMAN; NONSENSE MEDIATED MRNA DECAY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; STRUCTURE ANALYSIS; WILD TYPE;

ANIMALS; CELL LINE; CULLIN PROTEINS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; POLYRIBOSOMES; RIBONUCLEOPROTEINS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84856855006     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102837     Document Type: Article

References (46)

1. Beutler, B., and A. Cerami. 1989. The biology of cachectin/TNF - a primary mediator of the host response. Annu. Rev. Immunol. 7: 625-655. (Pubitemid 19138027)
2. Kontoyiannis, D., M. Pasparakis, T. T. Pizarro, F. Cominelli, and G. Kollias. 1999. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10: 387-398. (Pubitemid 29165293)
3. Anderson, P. 2010. Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nat. Rev. Immunol. 10: 24-35.
4. Boutaud, O., D. A. Dixon, J. A. Oates, and H. Sawaoka. 2003. Tristetraprolin binds to the COX-2 mRNA 3′ untranslated region in cancer cells. Adv. Exp. Med. Biol. 525: 157-160. (Pubitemid 36686690)
5. Brooks, S. A., J. E. Connolly, and W. F. Rigby. 2004. The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway. J. Immunol. 172: 7263-7271. (Pubitemid 38747585)
6. Carballo, E., W. S. Lai, and P. J. Blackshear. 1998. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281: 1001-1005. (Pubitemid 28399252)
7. Carballo, E., W. S. Lai, and P. J. Blackshear. 2000. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 95: 1891-1899. (Pubitemid 30151623)
8. Linker, K., A. Pautz, M. Fechir, T. Hubrich, J. Greeve, and H. Kleinert. 2005. Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR. Nucleic Acids Res. 33: 4813-4827. (Pubitemid 41418881)
9. Ogilvie, R. L., M. Abelson, H. H. Hau, I. Vlasova, P. J. Blackshear, and P. R. Bohjanen. 2005. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay. J. Immunol. 174: 953-961. (Pubitemid 40094291)
10. Phillips, K., N. Kedersha, L. Shen, P. J. Blackshear, and P. Anderson. 2004. Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor alpha, cyclooxygenase 2, and inflammatory arthritis. Proc. Natl. Acad. Sci. USA 101: 2011-2016. (Pubitemid 38229006)
11. Stoecklin, G., X. F. Ming, R. Looser, and C. Moroni. 2000. Somatic mRNA turnover mutants implicate tristetraprolin in the interleukin-3 mRNA degradation pathway. Mol. Cell. Biol. 20: 3753-3763. (Pubitemid 30314475)
12. Clement, S. L., C. Scheckel, G. Stoecklin, and J. Lykke-Andersen. 2011. Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment. Mol. Cell. Biol. 31: 256-266.
13. Sandler, H., J. Kreth, H. T. Timmers, and G. Stoecklin. 2011. Not1 mediates recruitment of the deadenylase Caf1 to mRNAs targeted for degradation by tristetraprolin. Nucleic Acids Res. 39: 4373-4386.
14. Chen, C. Y., R. Gherzi, S. E. Ong, E. L. Chan, R. Raijmakers, G. J. Pruijn, G. Stoecklin, C. Moroni, M. Mann, and M. Karin. 2001. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 107: 451-464. (Pubitemid 33152781)
15. Lykke-Andersen, J., and E. Wagner. 2005. Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1. Genes Dev. 19: 351-361. (Pubitemid 40189298)
16. Mukherjee, D., M. Gao, J. P. O'Connor, R. Raijmakers, G. Pruijn, C. S. Lutz, and J. Wilusz. 2002. The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements. EMBO J. 21: 165-174. (Pubitemid 34087085)
17. Kedersha, N., G. Stoecklin, M. Ayodele, P. Yacono, J. Lykke-Andersen, M. J. Fritzler, D. Scheuner, R. J. Kaufman, D. E. Golan, and P. Anderson. 2005. Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J. Cell Biol. 169: 871-884. (Pubitemid 41002864)
18. Stoecklin, G., T. Stubbs, N. Kedersha, S. Wax, W. F. Rigby, T. K. Blackwell, and P. Anderson. 2004. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J. 23: 1313-1324. (Pubitemid 38525003)
19. Pfeiffer, J. R., B. L. McAvoy, R. E. Fecteau, K. M. Deleault, and S. A. Brooks. 2011. CARHSP1 is required for effective TNF-α mRNA stabilization and localizes to processing bodies and exosomes. Mol. Cell. Biol. 31: 277-286.
20. Jackson, S., and Y. Xiong. 2009. CRL4s: the CUL4-RING E3 ubiquitin ligases. Trends Biochem. Sci. 34: 562-570.
21. Kerzendorfer, C., L. Hart, R. Colnaghi, G. Carpenter, D. Alcantara, E. Outwin, A. M. Carr, and M. O'Driscoll. 2011. CUL4B-deficiency in humans: understanding the clinical consequences of impaired Cullin 4-RING E3 ubiquitin ligase function. Mech. Ageing Dev. 132: 366-373.
22. Yokoyama, A., Z. Wang, J. Wysocka, M. Sanyal, D. J. Aufiero, I. Kitabayashi, W. Herr, and M. L. Cleary. 2004. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol. Cell. Biol. 24: 5639-5649. (Pubitemid 38787950)
23. Nakagawa, T., and Y. Xiong. 2011. X-linked mental retardation gene CUL4B targets ubiquitylation of H3K4 methyltransferase component WDR5 and regulates neuronal gene expression. Mol. Cell 43: 381-391.
24. Ohtake, F., A. Baba, I. Takada, M. Okada, K. Iwasaki, H. Miki, S. Takahashi, A. Kouzmenko, K. Nohara, T. Chiba, et al. 2007. Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 446: 562-566. (Pubitemid 46514731)
25. Cox, B. J., M. Vollmer, O. Tamplin, M. Lu, S. Biechele, M. Gertsenstein, C. van Campenhout, T. Floss, R. Kühn, W. Wurst, et al. 2010. Phenotypic annotation of the mouse X chromosome. Genome Res. 20: 1154-1164.
26. Zou, Y., Q. Liu, B. Chen, X. Zhang, C. Guo, H. Zhou, J. Li, G. Gao, Y. Guo, C. Yan, et al. 2007. Mutation in CUL4B, which encodes a member of cullin-RING ubiquitin ligase complex, causes X-linked mental retardation. Am. J. Hum. Genet. 80: 561-566.
27. Gassmann, M., B. Grenacher, B. Rohde, and J. Vogel. 2009. Quantifying Western blots: pitfalls of densitometry. Electrophoresis 30: 1845-1855.
28. Mathews, D. H., J. Sabina, M. Zuker, and D. H. Turner. 1999. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J. Mol. Biol. 288: 911-940. (Pubitemid 29248642)
29. Kedersha, N., and P. Anderson. 2007. Mammalian stress granules and processing bodies. Methods Enzymol. 431: 61-81.
30. Deleault, K. M., S. J. Skinner, and S. A. Brooks. 2008. Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways. Mol. Immunol. 45: 13-24. (Pubitemid 47331659)
31. Brooks, S. A., J. E. Connolly, R. J. Diegel, R. A. Fava, and W. F. Rigby. 2002. Analysis of the function, expression, and subcellular distribution of human tristetraprolin. Arthritis Rheum. 46: 1362-1370. (Pubitemid 34525846)
32. Rigby, W. F., K. Roy, J. Collins, S. Rigby, J. E. Connolly, D. B. Bloch, and S. A. Brooks. 2005. Structure/function analysis of tristetraprolin (TTP): p38 stress-activated protein kinase and lipopolysaccharide stimulation do not alter TTP function. J. Immunol. 174: 7883-7893. (Pubitemid 40806298)
33. Skinner, S. J., K. M. Deleault, R. Fecteau, and S. A. Brooks. 2008. Extracellular signal-regulated kinase regulation of tumor necrosis factor-alpha mRNA nucleocytoplasmic transport requires TAP-NxT1 binding and the AU-rich element. J. Biol. Chem. 283: 3191-3199.
34. Johnson, B. A., M. Geha, and T. K. Blackwell. 2000. Similar but distinct effects of the tristetraprolin/TIS11 immediate-early proteins on cell survival. Oncogene 19: 1657-1664. (Pubitemid 30200967)
35. Brook, M., C. R. Tchen, T. Santalucia, J. McIlrath, J. S. Arthur, J. Saklatvala, and A. R. Clark. 2006. Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways. Mol. Cell. Biol. 26: 2408-2418. (Pubitemid 43346939)
36. Ronkina, N., A. Kotlyarov, O. Dittrich-Breiholz, M. Kracht, E. Hitti, K. Milarski, R. Askew, S. Marusic, L. L. Lin, M. Gaestel, and J. B. Telliez. 2007. The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK. Mol. Cell. Biol. 27: 170-181. (Pubitemid 46013242)
37. Parker, R., and U. Sheth. 2007. P bodies and the control of mRNA translation and degradation. Mol. Cell 25: 635-646. (Pubitemid 46341926)
38. Gécz, J., C. Shoubridge, and M. Corbett. 2009. The genetic landscape of intellectual disability arising from chromosome X. Trends Genet. 25: 308-316.
39. Iwase, S., F. Lan, P. Bayliss, L. de la Torre-Ubieta, M. Huarte, H. H. Qi, J. R. Whetstine, A. Bonni, T. M. Roberts, and Y. Shi. 2007. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 128: 1077-1088. (Pubitemid 46437259)
40. Tahiliani, M., P. Mei, R. Fang, T. Leonor, M. Rutenberg, F. Shimizu, J. Li, A. Rao, and Y. Shi. 2007. The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature 447: 601-605. (Pubitemid 46868038)
41. Kleine-Kohlbrecher, D., J. Christensen, J. Vandamme, I. Abarrategui, M. Bak, N. Tommerup, X. Shi, O. Gozani, J. Rappsilber, A. E. Salcini, and K. Helin. 2010. A functional link between the histone demethylase PHF8 and the transcription factor ZNF711 in X-linked mental retardation. Mol. Cell 38: 165-178.
42. Ostareck, D. H., A. Ostareck-Lederer, I. N. Shatsky, and M. W. Hentze. 2001. Lipoxygenase mRNA silencing in erythroid differentiation: The 3′UTR regulatory complex controls 60S ribosomal subunit joining. Cell 104: 281-290. (Pubitemid 32174843)
43. Dumitru, C. D., J. D. Ceci, C. Tsatsanis, D. Kontoyiannis, K. Stamatakis, J. H. Lin, C. Patriotis, N. A. Jenkins, N. G. Copeland, G. Kollias, and P. N. Tsichlis. 2000. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103: 1071-1083. (Pubitemid 32040907)
44. Taylor, G. A., E. Carballo, D. M. Lee, W. S. Lai, M. J. Thompson, D. D. Patel, D. I. Schenkman, G. S. Gilkeson, H. E. Broxmeyer, B. F. Haynes, and P. J. Blackshear. 1996. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4: 445-454. (Pubitemid 26354654)
45. Hitti, E., T. Iakovleva, M. Brook, S. Deppenmeier, A. D. Gruber, D. Radzioch, A. R. Clark, P. J. Blackshear, A. Kotlyarov, and M. Gaestel. 2006. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol. Cell. Biol. 26: 2399-2407. (Pubitemid 43346938)
46. Marchese, F. P., A. Aubareda, C. Tudor, J. Saklatvala, A. R. Clark, and J. L. Dean. 2010. MAPKAP kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting CAF1 deadenylase recruitment. J. Biol. Chem. 285: 27590-27600.